Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201205103 Principal Investigator: DiPersio, John
Title: Study of the Anti-EphA3 Monoclonal Antibody KB004 in Subjects with EphA3-Expressing Hematologic Malignancies
Phase: Pilot Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The main purpose of this clinical research study is to find the highest tolerable dose of the study drug KB004, which is being tested as a possible therapy for people with different
types of blood cancer (leukemia
as well as other blood cancers). This study will also explore whether KB004 is safe for people to take and see how KB004 is absorbed by the body.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)